Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Hoffmann-La Roche
Scientific Title
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab (Anti-Tigit Antibody) in Patients With Untreated Extensive-Stage Small Cell Lung Cancer